| X23-07-YM034 |
Heparin disaccharide with structure ∆UA,2S-GlcN from porcine intestinal mucosa, White powder
|
|
| X23-07-YM035 |
Heparin disaccharide with structure ∆UA,2S-GlcN,6S from porcine intestinal mucosa, White powder
|
|
| X23-07-YM036 |
Heparin disaccharide with structure ∆UA-GlcN,6S from porcine intestinal mucosa, White powder
|
|
| X23-07-YM037 |
Heparin disaccharide with structure ∆UA-GlcN from porcine intestinal mucosa, White powder
|
|
| X23-07-YM038 |
Heparin disaccharide mix from porcine intestinal mucosa, Solution
|
|
| X23-07-YM039 |
Heparin unsaturated disaccharide II-H sodium salt, MW 439.32 Da
|
|
| X23-07-YM040 |
Heparin unsaturated disaccharide III-H sodium salt, MW 439.32 Da
|
|
| X23-11-ZQ061 |
Lactose-PEG-N3
|
|
| X23-11-ZQ062 |
Ac7lactose-PEG-N3
|
|
| X23-11-ZQ063 |
N3-LacNAc
|
|
| X23-11-ZQ064 |
N3-LacNAc-Oxa
|
|
| X23-11-ZQ080 |
(HSO4-6-)Galβ(1-4)GlcNAc
|
|
| X23-11-ZQ081 |
(HSO4-3-)Galβ(1-4)Glc
|
|
| X23-11-ZQ084 |
Lactose-PEG-NH2
|
|
| X23-11-ZQ085 |
LacNAc-PEG-NH2
|
|
| X23-11-ZQ821 |
Trehalose-6,6'-dibehenate
|
|
| X23-11-ZQ822 |
β-D-Gentiobiose octaacetate
|
|
| X23-11-ZQ823 |
β-D-Lactose octaacetate
|
|
| X23-11-ZQ824 |
Hepta-O-acetyl-α-D-lactosyl bromide
|
|
| X24-03-LY140 |
β-D-Maltose octaacetate
|
|
| X24-03-LY189 |
Octyl 4-O-α-D-glucopyranosyl-b-D-glucopyranoside
|
|
| X24-03-LY195 |
Maltobionic acid
|
|
| X24-03-LY197 |
Decyl β-D-maltopyranoside
|
|
| X24-03-LY210 |
Hexadecyl β-D-maltoside
|
|
| X24-03-LY249 |
4-O-β-D-Glucopyranosyl-D-glucitol
|
|
| X24-03-LY289 |
(2R, 3S, 4S, 5R, 6S)-2-(Acetoxymethyl)-6-(((2R, 3R, 4S, 5R, 6R)-4, 5-diacetoxy-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3, 4, 5-triyl tria
|
|
| X24-03-LY715 |
(2R,3R,4R,5S,6R)-2-Phenethoxy-6-((((3R,4R,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methoxy)methyl)tetrahydro-2H-pyran-3,4,5-triol
|
|
| X24-04-QCY274 |
6-O-(b-D-Glucopyranosyl)-D-fructose
|
|
| X24-04-QCY290 |
Lactose 6'-O-sulfate
|
|
| X24-04-XQ049 |
O-(2-Azido-4,6-O-benzylidene-2-deoxy-α-D-galactopyranosyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine tert-butyle ester, MW 658.71, ≥92%
|
|
| X24-04-XQ087 |
N-Dodecyl β-D-maltoside, MW 510.62, ≥99%
|
|
| X24-04-XQ101 |
Lactosum, MW 342.3, ≥98%
|
|
| X24-04-XQ119 |
Sodium lactobionate, MW 398.29, ≥99%
|
|
| X24-04-XQ128 |
Iron saccharate, MW 736.06, ≥98%
|
|
| X24-04-XQ129 |
Sucrose benzoate, MW 446.4, ≥98%
|
|
| X24-04-XQ143 |
Alpha-d-glucopyranoside, MW 608.76, ≥98%
|
|
| X24-04-XQ153 |
Delphinidin-3,5-diglucoside, MW 663, ≥95%
|
|
| X24-04-XQ161 |
Neoagarobiose, MW 324.28, ≥98%
|
|
| X24-04-XQ183 |
Sucrose solution, 20,000 μg/mL, MW 342.3
|
|
| X25-02-ZQ1000 |
Streptavidins reagent, Streptavidins-PEG-lactosyl, PEG 350 Da, Purity ≥95%
|
|
